Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
100
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Fractyl Health Inc. market cap is $10.88M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Fractyl Health Inc. 52 week high is $29.34 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Fractyl Health Inc. 52 week low is $0.784 as of November 22, 2026.
Fractyl Health Inc. stock price today is $0.82.
Fractyl Health Inc. stock price yesterday was $0.9553.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Fractyl Health Inc.'s P/E ratio is -0.14.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Fractyl Health Inc. P/B ratio is -0.823.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Fractyl Health Inc. 50-day moving average is $3.20.